Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib
about
The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors.Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis.Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma.Neutrophil-to-lymphocyte ratio predicts survival in European patients with hepatocellular carcinoma administered sorafenib.Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
P2860
Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Prognostic significance of adv ...... rcinoma treated with sorafenib
@ast
Prognostic significance of adv ...... rcinoma treated with sorafenib
@en
Prognostic significance of adv ...... rcinoma treated with sorafenib
@nl
type
label
Prognostic significance of adv ...... rcinoma treated with sorafenib
@ast
Prognostic significance of adv ...... rcinoma treated with sorafenib
@en
Prognostic significance of adv ...... rcinoma treated with sorafenib
@nl
prefLabel
Prognostic significance of adv ...... rcinoma treated with sorafenib
@ast
Prognostic significance of adv ...... rcinoma treated with sorafenib
@en
Prognostic significance of adv ...... rcinoma treated with sorafenib
@nl
P2093
P2860
P356
P1476
Prognostic significance of adv ...... rcinoma treated with sorafenib
@en
P2093
Francesca Benevento
Giulia Negrini
Luigi Bolondi
Saverio Menetti
P2860
P304
P356
10.1177/1756283X15618129
P407
P577
2016-03-01T00:00:00Z